Status:
NOT_YET_RECRUITING
Tacrolimus Eye Drops in Treatment of Vernal Keratoconjunctivitis
Lead Sponsor:
Sohag University
Conditions:
Vernal Keratoconjunctivitis
Eligibility:
All Genders
5-15 years
Phase:
NA
Brief Summary
The purpose of the study is to evaluate efficacy and safety of topical Tacrolimus eye drops in different concentrations in treatment of vernal keratoconjunctivitis (VKC) comparing it with Steroid base...
Detailed Description
A hospital- based Prospective comparative randomized open label controlled trial . the study will be conducted on Patients with moderate to severe active VKC aged between (5-15) years old (pediatric a...
Eligibility Criteria
Inclusion
- Patients with moderate to severe active VKC aged between (5-15) years old (pediatric age group)
Exclusion
- Coexisting eye infections
- Contact lens use
- Systemic immunosuppressive drug use
- Herpes keratitis
- Recent ocular surgery or trauma
- Known hypersensitivity to Tacrolimus
- Ophthalmological comorbidities as cataract, glaucoma, and congenital eye anomalies
- Impaired renal or hepatic functions
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT07138742
Start Date
September 1 2025
End Date
September 1 2027
Last Update
August 24 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.